Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1RAs, like semaglutide and tirzepatide, may cause hair loss, so patients should be informed and monitored.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Finasteride and dutasteride may help prevent hair loss but could cause side effects like sexual dysfunction and psychological issues.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Genetic variations affecting skin structure play a key role in severe acne.

Transgender patients face more barriers to oral healthcare, leading to poorer oral health and quality of life.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia significantly impacts mental health and quality of life, requiring psychological support.

PCOS causes hormonal issues and infertility, with treatment options including medication and lifestyle changes.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Hair loss can cause low self-esteem, anxiety, and depression in men.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Low levels of BDNF and vitamin D are linked to higher depression in alopecia areata and vitiligo patients.

Gender-diverse individuals face more depression and anxiety, possibly due to unique stress profiles.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Women with PCOS are more likely to experience depression and have a negative body image compared to women without PCOS.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

Women who lost hair from childhood head radiation are more likely to face mental health issues than men.

Finasteride use may cause sexual dysfunction; more research needed.

Women with polycystic ovarian syndrome often experience depression and anxiety.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

Oral isotretinoin was recommended for a 21-year-old woman with severe acne.

Hair cortisol could be a marker for chronic stress in pregnancy, but depression affects cortisol levels differently.